Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Eshbal Acquires a 55% Interest in Dare to Be Different Foods (click to learn more) CSE: ALEN.U — AI Meets Digital Health (click to learn more) What’s Behind Cannabis Stock HERB? (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Stock Quote Today & Recent News Precipio Inc PRPO

Healthcare Diagnostics & Research
Precipio, Inc., a healthcare biotechnology company, provides cancer diagnostic products, reagents, and services in the United States. It provides diagnostic blood cancer testing services. The company offers IV-Cell, a proprietary cell culture media that enables simultaneous culturing of four hematopoietic cell lineages; and HemeScreen, a suite of robust genetic diagnostic panels. It offers... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:PRPO)

Precipio Takes Major Steps Toward a Clean Balance Sheet

GlobeNewswire January 15, 2026

Precipio to Showcase its BCR::ABL1 panel at 2025 ASH (American Society of Hematology) Meeting

GlobeNewswire December 5, 2025

Precipio Identifies Unauthorized Access to Isolated Storage; No Operational Impact

GlobeNewswire December 4, 2025

Precipio Announces its Q3-2025 Financial Results

GlobeNewswire November 14, 2025

Precipio Announces Q3-2025 Shareholder Update Call

GlobeNewswire November 4, 2025

Precipio Terminates Its ATM

GlobeNewswire September 2, 2025

Precipio Announces its Q2-2025 Financial Results

GlobeNewswire August 13, 2025

Precipio Announces Q2-2025 Shareholder Update Call

GlobeNewswire July 31, 2025

Precipio Enters Into Agreement With Warrant Holder To Exercise Majority Of Warrants As Cashless

GlobeNewswire July 11, 2025
View More News ››

Opinion & Analysis (NDAQ:PRPO)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NDAQ:PRPO)

Precipio, Inc. (NASDAQ:PRPO): Addressing Cancer Misdiagnosis

http://beyondspx.com/2024/08/01/precipio-inc-nasdaqprpo-addressing-cancer-misdiagnosis-through-innovative-diagnostics/
MikeTester - August 1, 2024

PRPO..... Stopped out

sorry for late post
Iseneschal - September 15, 2022

PRPO .... On watch

Might run ..... JMHO
Iseneschal - September 15, 2022

RE:RE:RE:PRPO.......Heads up

There it is..... 2nd Target met Don't quit your "Day Job"
Iseneschal - May 10, 2021

Holding

85,000
Toad09 - May 10, 2021

RE:RE:PRPO.......Heads up

 PRPO...... 1st target reached Now what ??
Iseneschal - May 10, 2021
View more Bullboard ››

Kobrea Exploration Corp.

Kobrea Exploration Corp.

Kobrea Exploration Corp. engages in the acquisition, exploration, and evaluation of mineral properties in Canada. It holds a ...
View More »

Podcasts